Navigation Links
$2.5 Million Gift Aims to Help Children Survive and Thrive
Date:3/24/2010

Dr. David Wessel Named IKARIA® Distinguished Professor of Critical Care Medicine at Children’s National Medical Center

Washington, DC (Vocus) March 24, 2010 -- On Tuesday Children’s National Medical Center appointed David L. Wessel, MD, as the first IKARIA® Distinguished Professor of Critical Care Medicine. Dr. Wessel is the division chief and senior vice president of hospital-based specialties and is internationally known for his pioneering work in caring for infants with heart disease.

The $2.5 million endowment was created by IKARIA, a biotherapeutics company whose acute care products and therapies address the significant unmet needs of critically ill patients.

“The dedication of the health care professionals who work in the critical care environment is our constant inspiration,” said Daniel Tassé, chairman and chief executive officer of IKARIA. “Caring for critically ill patients demands commitment, passion and perseverance, and we are honored to have the opportunity to recognize the outstanding work of Dr. David Wessel, who has demonstrated extraordinary achievement in this area.”

Edwin K. Zechman Jr., president and CEO of Children’s National, said, “We are grateful for IKARIA’s generosity and commitment to improving the care of our most vulnerable patients. This partnership will be life-changing – and life-saving – for so many.”

Dr. Wessel said, “We are convinced that refining critical care treatments will improve long-term physical and developmental outcomes for our young patients. At Children’s National Medical Center, our goal is for children to not only survive, but thrive.”

Educated and trained in medicine at Oxford, Yale and Harvard, Dr. Wessel joined Children’s National Medical Center in July 2007. Prior to joining Children’s National he was professor of pediatrics at Harvard Medical School and senior associate in cardiology and anesthesia at Children’s Hospital Boston. He is board certified in anesthesiology, pediatrics, pediatric cardiology and pediatric critical care medicine.

An experienced scientist and clinical researcher with over 100 peer-reviewed publications, Dr. Wessel has made seminal contributions to the field of critical care medicine. Widely viewed as the “father of pediatric cardiac intensive care,” he has trained a vast number of practicing clinical leaders in the field. Dr. Wessel has also been listed as one of the “Best Doctors in America” continuously since the inception of the ranking.

Dr. Wessel is married and has four children.

Contact Stacy Williams, 301-565-8523, stwillia(at)cnmc(dot)org

About Children’s National Medical Center
Children's National Medical Center, located in Washington, DC, is a proven leader in the development of innovative new treatments for childhood illness and injury. Children’s has been serving the nation's children for more than 135 years. Children’s National is ranked among the best pediatric hospitals in America by US News & World Report and the Leapfrog Group. For more information, visit www.ChildrensNational.org.

About IKARIA Holdings, Inc.
Ikaria Holdings, Inc. is a biotherapeutics company whose acute care products and therapies address the significant unmet needs of critically ill patients. The company’s lead product, INOMAX® (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns, and also is marketed in Canada, Europe, Latin America, Australia, Japan and Mexico. Ikaria is engaged in new and ongoing clinical development of INOMAX and hydrogen sulfide. Ikaria acquired the North American rights to terlipressin, a potential treatment for hepatorenal syndrome Type 1, as well as the exclusive worldwide licenses to BL-1040, a potential breakthrough treatment for preventing pathological cardiac remodeling following acute myocardial infarction, and to a portfolio of investigational compounds focused on vascular leakage for a range of critical care conditions, such as acute lung and kidney injury. Ikaria is headquartered in Clinton, N.J., with research facilities in Seattle, Wash., and Madison, Wisc., and a manufacturing facility in Port Allen, La. For more information, visit www.ikaria.com.

###

Read the full story at http://www.prweb.com/releases/childrens-national/IKARIA-Holdings/prweb3773644.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. GSK Joins Global Vaccine Alliance to Help Prevent Millions of Children from Contracting Pneumococcal Disease in the Worlds Poorest Countries
2. New York College of Osteopathic Medicine (NYCOM) at NYIT Awarded $1 Million Federal Grant
3. Wireless LAN Innovator Aerohive Secures $23.5 Million Series C Investment
4. Bloomberg School of Public Health awarded $15 million for laboratory renovation and modernization
5. Massage Envy Performs 20 Millionth Massage
6. PROLOR Biotech Announces Sale of $24.4 Million of Common Stock
7. National Center for Policy Analysis and Salem Radio Network Deliver One Million Emails to Congress to Stop ObamaCare
8. Democracy on Trial: SEIUs $25 Million Lawsuit Against Union Reformers Goes to Court Monday
9. 27th Annual Shamrocks Against Dystrophy Sets $20 Million Fundraising Record
10. Non-Melanoma Skin Cancers in the Millions and Rising
11. Online Medical Supplies Superstore Ships 1 Millionth Order
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
$2.5 Million Gift Aims to Help Children Survive and Thrive
(Date:1/16/2017)... MO (PRWEB) , ... January 16, 2017 , ... St. Louisans are well-aware of the ... , This year’s influenza shot seems to be having no effect on keeping ... at least half of the people around are coughing, sneezing, or sniffling ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to ... treat, but to test for, as well. The money spent screening for and treating ... in the U.S. screen patients for cancer more than in any other country that ...
(Date:1/15/2017)... , ... January 15, 2017 , ... In this role, ... the United States for the asthma & allergy friendly mark. This certification program was ... test and identify consumer products to be more suitable for the 60+ million people ...
(Date:1/15/2017)... ... January 15, 2017 , ... "On Tour is a music themed slideshow production ... said Christina Austin - CEO of Pixel Film Studios. , On Tour’s new ... style and animation of their slideshows. Place each slide on top of another slide ...
(Date:1/15/2017)... ... January 15, 2017 , ... ... NJ is pleased to announce that it will be assisting HackensackUMC Mountainside with ... and Glen Ridge townships, servicing all surrounding towns. The firm will be working ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... 2017 According to the new market research report ... , Smart Display, Graphic LCD Controller), Application (Industrial Control, Medical Equipment, Automotive, ... the market is expected to grow from USD 17.26 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
(Date:1/16/2017)... LOVELAND, Colo. , Jan. 16, 2017  Northern ... , is bringing advanced laser treatments to ... specialty clinic focuses solely on the removal of unwanted ... and fading for tattoo cover-ups. "Tattoos are ... out the way we hope they would," said ...
(Date:1/16/2017)... , January 16, 2017 ... Market by Product Type (Methyl, Ethyl, Hydroxyethyl, Hydroxypropyl, ... & Beverages, Surface Coatings & Paints), Region ... MarketsandMarkets, the market was valued at USD ... to reach USD 6.41 Billion by 2021, ...
Breaking Medicine Technology: